Cargando…

Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer

Clinical evidence indicates that drug resistance is a great obstacle in breast cancer therapy. It renders the disease uncontrollable and causes high mortality. Multiple mechanisms contribute to the development of drug resistance, but the underlying cause is usually a shift in the genetic composition...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yinnan, Zhang, Yanmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010891/
https://www.ncbi.nlm.nih.gov/pubmed/29938175
http://dx.doi.org/10.1002/advs.201700964

Ejemplares similares